Hypokalemic periodic paralysis as the first sign of thyrotoxicosis- a rare case report from Somalia.

IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Thyroid Research Pub Date : 2023-06-12 DOI:10.1186/s13044-023-00158-4
Hawa Nuradin Mohamed, Abdi Karim Ahmed Ghedi, Sevgi Ozturk, Mohamed Osman Omar Jeele, Ahmed Muhammad Bashir
{"title":"Hypokalemic periodic paralysis as the first sign of thyrotoxicosis- a rare case report from Somalia.","authors":"Hawa Nuradin Mohamed,&nbsp;Abdi Karim Ahmed Ghedi,&nbsp;Sevgi Ozturk,&nbsp;Mohamed Osman Omar Jeele,&nbsp;Ahmed Muhammad Bashir","doi":"10.1186/s13044-023-00158-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thyrotoxic hypokalemic periodic paralysis (THPP) is a rare complication of hyperthyroidism characterized by thyrotoxicosis, hypokalemia, and paralysis. It is the most common form of acquired periodic paralysis. THPP is precipitated by strenuous exercise, a high carbohydrate diet, stress, infection, alcohol, albuterol, and corticosteroid therapy. It is most common in Asian men with hyperthyroidism and exceptionally rare in black people.</p><p><strong>Case presentation: </strong>A 29-year-old man was admitted to the emergency department in Somalia with a sudden onset of paralysis after a high carbohydrate meal. Laboratory investigations showed low serum potassium 1.8 mEq/l (3.5-4.5), and biochemical thyrotoxicosis with TSH 0.006 miu/l (0.35-5.1), total T3 3.2 ng/ml (0.9-2.8) and total T4 13.5 ng/ml (0.6-1.2). He was successfully treated with potassium chloride infusion and an antithyroid drug, methimazole.</p><p><strong>Conclusion: </strong>To prevent life-threatening cardiac and respiratory complications, it is critical to consider and diagnose THPP early, even in populations where the condition is rare.</p>","PeriodicalId":39048,"journal":{"name":"Thyroid Research","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258971/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13044-023-00158-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Thyrotoxic hypokalemic periodic paralysis (THPP) is a rare complication of hyperthyroidism characterized by thyrotoxicosis, hypokalemia, and paralysis. It is the most common form of acquired periodic paralysis. THPP is precipitated by strenuous exercise, a high carbohydrate diet, stress, infection, alcohol, albuterol, and corticosteroid therapy. It is most common in Asian men with hyperthyroidism and exceptionally rare in black people.

Case presentation: A 29-year-old man was admitted to the emergency department in Somalia with a sudden onset of paralysis after a high carbohydrate meal. Laboratory investigations showed low serum potassium 1.8 mEq/l (3.5-4.5), and biochemical thyrotoxicosis with TSH 0.006 miu/l (0.35-5.1), total T3 3.2 ng/ml (0.9-2.8) and total T4 13.5 ng/ml (0.6-1.2). He was successfully treated with potassium chloride infusion and an antithyroid drug, methimazole.

Conclusion: To prevent life-threatening cardiac and respiratory complications, it is critical to consider and diagnose THPP early, even in populations where the condition is rare.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
低钾性周期性麻痹是甲状腺毒症的第一个症状——索马里罕见病例报告。
背景:甲状腺毒性低钾血症周期性麻痹(THPP)是一种罕见的甲状腺功能亢进并发症,以甲状腺毒症、低钾血症和麻痹为特征。这是获得性周期性麻痹最常见的形式。THPP可由剧烈运动、高碳水化合物饮食、压力、感染、酒精、沙丁胺醇和皮质类固醇治疗引起。它在亚洲男性甲状腺机能亢进患者中最为常见,在黑人中极为罕见。病例介绍:索马里一名29岁男子在高碳水化合物餐后突然瘫痪,被送往急诊科。实验室检查显示低血钾1.8 mEq/l(3.5-4.5),生化甲状腺毒症TSH 0.006 miu/l(0.35-5.1),总T3 3.2 ng/ml(0.9-2.8),总T4 13.5 ng/ml(0.6-1.2)。他成功地接受了氯化钾输注和抗甲状腺药物甲巯咪唑的治疗。结论:为了预防危及生命的心脏和呼吸系统并发症,早期考虑和诊断THPP至关重要,即使在罕见的人群中也是如此。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Thyroid Research
Thyroid Research Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
3.10
自引率
4.50%
发文量
21
审稿时长
8 weeks
期刊最新文献
Losartan is more effective than angiotensin (1-7) in preventing thyroxine-induced renal injury in the rat. The diagnostic performance of neck ultrasound in follow-up of advanced stage differentiated thyroid cancer. Sonographic characteristics of thyroid nodules with a Halo. Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements. Identification of LINC02454-related key pathways and genes in papillary thyroid cancer by weighted gene coexpression network analysis (WGCNA).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1